Finn Patrick John's Form 4 filing
Twist Bioscience Corp (TWST) · filed Sep 7, 2021
- Accession no.
- 0001214659-21-009352
- Filed
- Sep 7, 2021
- Trade date
- Sep 2, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $318.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Finn Patrick JohnCIK 0001755970 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Common Stock | MOption exerciseAcquired | +358 | $8.82 | +$3,157.56 | 40,181 | Direct | |
| Sep 2, 2021 | Common Stock | MOption exerciseAcquired | +1,517 | $26.66 | +$40,443.22 | 41,698 | Direct | |
| Sep 2, 2021 | Common Stock | MOption exerciseAcquired | +827 | $23.33 | +$19,293.91 | 42,525 | Direct | |
| Sep 2, 2021 | Common Stock | SSaleDisposed | −2,702 | $117.99 | −$318,808.98 | 39,823 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Common Stock | MOption exerciseDisposed | −358 | $0.00 | $0 | 15,625 | Direct | |
| Sep 2, 2021 | Common Stock | MOption exerciseDisposed | −1,517 | $0.00 | $0 | 39,442 | Direct | |
| Sep 2, 2021 | Common Stock | MOption exerciseDisposed | −827 | $0.00 | $0 | 21,513 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.